English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Tuesday, August 19, 2025
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers
16:00 HKT/SGT
Hitachi High-Tech and NOF Metal Coatings use materials informatics to improve the efficiency and sophistication of research and development work

15:38 HKT/SGT
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers
15:00 HKT/SGT
CENTRESTAGE 10th anniversary set to dazzle in September
12:00 HKT/SGT
康哲藥業(867.HK,8A8.SG)上半年營收淨利雙升 戰略轉型跑出增長新動能
11:53 HKT/SGT
康哲药业(867.HK,8A8.SG)上半年营收净利双升 战略转型跑出增长新动能
11:53 HKT/SGT
NEC and ClimateAi Develop Conceptual Model to Promote Climate Change Adaptation in Agriculture
10:33 HKT/SGT
富士通、Palantirとの戦略的なグローバルパートナーシップを強化し、企業における生成AIの業務実装と業務変革支援を加速
10:30 HKT/SGT
Value Research Center to host The Valuism Conference 2025 on August 28-29 (Hybrid Format)
10:00 HKT/SGT
Fujitsu signs new licensing agreement with Palantir
09:55 HKT/SGT
「Valuism カンファレンス 2025」開催決定(8 月 28 日〜29 日・ハイブリッド形式)
09:00 HKT/SGT
Monday, August 18, 2025
The 35th Food Expo and concurrent fairs attract over 500,000 visits
20:07 HKT/SGT
Sino Biopharm (1177.HK) Announces 2025 Interim Results
19:11 HKT/SGT
中國生物製藥(1177.HK)公佈2025中期業績
19:11 HKT/SGT
中国生物制药(1177.HK)公布2025中期业绩
19:11 HKT/SGT
Focus Graphite Announces Board Changes and Upcoming International Trade Mission with Natural Resources Canada
18:00 HKT/SGT
Shuangdeng Group Proposed Listing on the Main Board of the Hong Kong Stock Exchange
17:28 HKT/SGT
雙登股份宣佈於香港聯交所主板上市計劃
17:28 HKT/SGT
Qunabox Group Deliver Strong H1 2025 Performance with Over 30% Growth in Revenue and Gross Profit
15:36 HKT/SGT
Team Mitsubishi Ralliart Triumphs at Asia Cross Country Rally 2025 with Chayapon Yotha's Overall Victory and Team Award
14:22 HKT/SGT
UNFPA and NEC Collaborate to Build Beneficiary Information Management and e-Voucher System
13:38 HKT/SGT
Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games
10:35 HKT/SGT
The Business Show Asia 2025 Set to Inspire, Connect, and Transform Businesses
10:30 HKT/SGT
勇奪12金14銀11銅 首程控股多家被投企業閃耀世界人形機器人運動會
10:23 HKT/SGT
Anime Tokyo Station Surpasses 200,000 Visitors
10:00 HKT/SGT
斩获12金14银11铜 摘得大满贯!首程控股多家被投企业闪耀世界人形机器人运动会
09:57 HKT/SGT
Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China
08:11 HKT/SGT
Saturday, August 16, 2025
How Do AI Workflow Automations Work?
00:00 HKT/SGT
Friday, August 15, 2025
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
20:15 HKT/SGT
艾曲莫德入選《2025 ACG臨床指南:成人潰瘍性結腸炎》,獲強烈推薦用於中重度潰瘍性結腸炎的誘導緩解及維持緩解治療
20:07 HKT/SGT
艾曲莫德入选《2025 ACG临床指南:成人溃疡性结肠炎》,获强烈推荐用于中重度溃疡性结肠炎的诱导缓解及维持缓解治疗
19:56 HKT/SGT
OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively
19:11 HKT/SGT
業聚醫療2025年中期業績收入及純利雙雙增長 分別達8,360萬美元及1,980萬美元
18:53 HKT/SGT
业聚医疗2025年中期业绩收入及纯利双双增长 分别达8,360万美元及1,980万美元
18:10 HKT/SGT
廣發証券榮膺國家數據管理能力成熟度(DCMM)最高等級認証
17:28 HKT/SGT
米国株式アクティブ残高10年連続世界No.1ティー・ロウ・プライス[1] 日本法人が既存追加型株式投資信託に「毎月決算・予想分配金提示型」ファンドを新規設定
17:15 HKT/SGT
广发证券荣膺国家数据管理能力成熟度(DCMM)最高等级认证
17:12 HKT/SGT
TANAKA Holds Press Conference to Commemorate Its 140th Anniversary
02:00 HKT/SGT
Thursday, August 14, 2025
WL Delicious Announced 2025 Interim Results
23:05 HKT/SGT
RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements
23:00 HKT/SGT
RAK ICC以2025年立法升級加強基金會制度
23:00 HKT/SGT
RAK ICC以2025年立法升级加强基金会制度
23:00 HKT/SGT
卫龙美味公佈2025年中期業績
22:48 HKT/SGT
卫龙美味公布2025年中期业绩
22:30 HKT/SGT
The 35th Food Expo opens today
21:05 HKT/SGT
 ACN Search:
 
Asian Financial Forum kicks off 2026 as region's first major event of 2026
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575